CAMBRIDGE, England--(BUSINESS WIRE)--Microbiotica, a leader in discovering and developing microbiome-based therapeutics and biomarkers, today announces it has entered into a clinical trial ...
The approval also covers Keytruda SC, known in the US as Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph).
The American pharmaceutical MSD receives hundreds of millions of euros in tax benefits in the Netherlands every year, ...
SUZHOU, China--(BUSINESS WIRE)--Evopoint Biosciences Co., Ltd.(“Evopoint”), a biopharmaceutical company focused on discovering and developing innovative and transformative medicines, announced today a ...
Once a company product is delivered through the legitimate supply chain to a distributor, the company does not have ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its first-quarter 2026 sales and earnings ...
MSD/Merck & Co's headquarters in Rahway, New Jersey. MSD has said it plans to separate its cancer and non-cancer pharma operations as it prepares for the looming loss of patent protection for $31 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results